These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 23408461)

  • 61. Magnetic resonance imaging and spectroscopy accurately estimate the severity of steatosis provided the stage of fibrosis is considered.
    McPherson S; Jonsson JR; Cowin GJ; O'Rourke P; Clouston AD; Volp A; Horsfall L; Jothimani D; Fawcett J; Galloway GJ; Benson M; Powell EE
    J Hepatol; 2009 Aug; 51(2):389-97. PubMed ID: 19505740
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Prerecovery liver biopsy in the brain-dead donor: a case-control study of logistics, safety, precision, and utility.
    Oliver JB; Peters S; Bongu A; Beidas AK; Dikdan G; Brown L; Koneru B
    Liver Transpl; 2014 Feb; 20(2):237-44. PubMed ID: 24382833
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Mild donor liver steatosis has no impact on hepatitis C virus fibrosis progression following liver transplantation.
    Botha JF; Thompson E; Gilroy R; Grant WJ; Mukherjee S; Lyden ER; Fox IJ; Sudan DL; Shaw BW; Langnas AN
    Liver Int; 2007 Aug; 27(6):758-63. PubMed ID: 17617118
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Oil Red O-assessed macrosteatosis in liver transplant donor biopsies predicts ischemia-reperfusion injury and clinical outcome.
    Reis H; Peterek PT; Wohlschlaeger J; Kaiser GM; Mathe Z; Juntermanns B; Sotiropoulos GC; Beckhove U; Canbay A; Wirges U; Scherag A; Treckmann JW; Paul A; Baba HA
    Virchows Arch; 2014 Feb; 464(2):165-74. PubMed ID: 24297629
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Use of bioelectrical impedance analysis to assess liver steatosis.
    Bhati CS; Silva MA; Wigmore SJ; Bramhall SR; Mayer DA; Buckels JA; Neil DA; Murphy N; Mirza DF
    Transplant Proc; 2009 Jun; 41(5):1677-81. PubMed ID: 19545706
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Liver steatosis quantification using magnetic resonance imaging: a prospective comparative study with liver biopsy.
    Mennesson N; Dumortier J; Hervieu V; Milot L; Guillaud O; Scoazec JY; Pilleul F
    J Comput Assist Tomogr; 2009; 33(5):672-7. PubMed ID: 19820490
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Improved assessment of donor liver steatosis using Banff consensus recommendations and deep learning algorithms.
    Gambella A; Salvi M; Molinaro L; Patrono D; Cassoni P; Papotti M; Romagnoli R; Molinari F
    J Hepatol; 2024 Mar; 80(3):495-504. PubMed ID: 38036009
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Reticulin loss in benign fatty liver: an important diagnostic pitfall when considering a diagnosis of hepatocellular carcinoma.
    Singhi AD; Jain D; Kakar S; Wu TT; Yeh MM; Torbenson M
    Am J Surg Pathol; 2012 May; 36(5):710-5. PubMed ID: 22498821
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Hepatic steatosis assessment: a comparative study between surgeon evaluation and forward histopathologic findings.
    Martins AM; Coelho GR; Marques GA; Moraes MO; Valença JT; Garcia JH
    Arq Gastroenterol; 2013; 50(1):15-8. PubMed ID: 23657301
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Development of an unbiased method for the estimation of liver steatosis.
    Fiorini RN; Kirtz J; Periyasamy B; Evans Z; Haines JK; Cheng G; Polito C; Rodwell D; Shafizadeh SF; Zhou X; Campbell C; Birsner J; Schmidt M; Lewin D; Chavin KD
    Clin Transplant; 2004 Dec; 18(6):700-6. PubMed ID: 15516247
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Approach to intraoperative consultation for donor liver biopsies.
    Melin C; Miick R; Young NA; Ortiz J; Balasubramanian M
    Arch Pathol Lab Med; 2013 Feb; 137(2):270-4. PubMed ID: 23368870
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Marginal grafts: finding the correct treatment for fatty livers.
    Salizzoni M; Franchello A; Zamboni F; Ricchiuti A; Cocchis D; Fop F; Brunati A; Cerutti E
    Transpl Int; 2003 Jul; 16(7):486-93. PubMed ID: 12669196
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A rapid and reliable means of assessing hepatic steatosis in vivo via electrical bioimpedance.
    Hessheimer AJ; Parramón D; Guimerà A; Erill I; Rimola A; García-Valdecasas JC; Villa R; Fondevila C
    Transplantation; 2009 Sep; 88(5):716-22. PubMed ID: 19741471
    [TBL] [Abstract][Full Text] [Related]  

  • 74. MORPHOLOGICAL CHANGES IN THE LIVER AFTER 8 HOURS OF PRESERVATION BY MACHINE PERFUSION.
    Kordzaia D; Khodeli N; Chkhaidze Z; Inauri N; Tsomaia K; Gogiashvili L
    Georgian Med News; 2019 Oct; (295):132-137. PubMed ID: 31804215
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Impact of steatotic grafts on initial function and prognosis after liver transplantation.
    Afonso RC; Saad WA; Parra OM; Leitão R; Ferraz-Neto BH
    Transplant Proc; 2004 May; 36(4):909-11. PubMed ID: 15194312
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Combined Effect of Deceased Donor Macrovesicular and Microvesicular Steatosis on Liver Transplantation Outcomes: Analysis of SRTR Data Between 2010 and 2018.
    Ayloo S; Molinari M; Pentakota SR
    Transplant Proc; 2021 Dec; 53(10):2971-2982. PubMed ID: 34740448
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Impact of Donor Liver Macrovesicular Steatosis on Deceased Donor Yield and Posttransplant Outcome.
    Kwong AJ; Kim WR; Lake J; Stock PG; Wang CJ; Wetmore JB; Melcher ML; Wey A; Salkowski N; Snyder JJ; Israni AK
    Transplantation; 2023 Feb; 107(2):405-409. PubMed ID: 36042548
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The role of hepatic biopsy to detect macrovacuolar steatosis during liver procurement.
    Adani GL; Baccarani U; Sainz-Barriga M; Lorenzin D; Bresadola V; Risaliti A; Avellini C; Trevisan G; De Candia A; Bresadola F
    Transplant Proc; 2006 Jun; 38(5):1404-6. PubMed ID: 16797317
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Living donor liver transplantation: histological abnormalities found on liver biopsies of apparently healthy potential donors.
    Tran TT; Changsri C; Shackleton CR; Poordad FF; Nissen NN; Colquhoun S; Geller SA; Vierling JM; Martin P
    J Gastroenterol Hepatol; 2006 Feb; 21(2):381-3. PubMed ID: 16509862
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Dual-echo, chemical shift gradient-echo magnetic resonance imaging to quantify hepatic steatosis: Implications for living liver donation.
    Rinella ME; McCarthy R; Thakrar K; Finn JP; Rao SM; Koffron AJ; Abecassis M; Blei AT
    Liver Transpl; 2003 Aug; 9(8):851-6. PubMed ID: 12884199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.